T helper-1 activation via interleukin-16 is a key phenomenon in the acute phase of severe, first-episode major depressive disorder and suicidal behaviors — Abbas F. Almulla (2023) | RDL Network
T helper-1 activation via interleukin-16 is a key phenomenon in the acute phase of severe, first-episode major depressive disorder and suicidal behaviors
Article 2023 en
Authors
AA
Abbas F. Almulla
AA
Ali Abbas Abo Algon
CT
Chavit Tunvirachaisakul
Abstract
1 min read
Immune-inflammatory pathways in major depressive disorder are confined to the major dysmood disorder (MDMD) phenotype (Maes et al., 2022). No studies have addressed the immune profile of first episode MDMD (FE-MDMD).
Discussion(0)
No comments yet. Be the first to comment.